In our experiments, we provided novel evidence that the ADF regimen improved atherogenic risk factors including obesity, hyperglycemia, and fatty liver, whereas deteriorated cholesterol profiles and accelerated the development of atherosclerosis in Apoe−/− mice fed with WD. This evidence concerns the gene APOE and obesity disorder.